ResMed Inc.
RMD
$245.73
-$13.29-5.13%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.49B | 1.44B | 1.40B | 1.31B | 1.25B |
| Total Depreciation and Amortization | 220.80M | 214.36M | 210.34M | 190.39M | 192.62M |
| Total Amortization of Deferred Charges | 25.40M | 25.41M | 25.47M | 25.89M | 26.39M |
| Total Other Non-Cash Items | 108.43M | 104.30M | 98.32M | 108.30M | 84.95M |
| Change in Net Operating Assets | 74.00M | 101.39M | 16.74M | 15.11M | -76.36M |
| Cash from Operations | 1.91B | 1.88B | 1.75B | 1.65B | 1.48B |
| Capital Expenditure | -122.89M | -114.99M | -89.87M | -84.16M | -84.56M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -139.10M | -139.77M | -139.25M | -20.37M | -23.45M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.03M | -9.00K | 29.07M | -8.31M | -6.21M |
| Cash from Investing | -269.02M | -254.77M | -200.05M | -112.84M | -114.21M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -10.00M | -10.00M | -40.00M | -335.00M | -555.00M |
| Issuance of Common Stock | 76.94M | 74.26M | 74.44M | 71.98M | 67.85M |
| Repurchase of Common Stock | -522.04M | -418.44M | -318.10M | -267.93M | -242.85M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -330.63M | -320.74M | -310.88M | -303.84M | -296.63M |
| Other Financing Activities | -10.86M | -10.86M | -11.71M | -855.00K | -855.00K |
| Cash from Financing | -796.58M | -685.77M | -606.25M | -835.65M | -1.03B |
| Foreign Exchange rate Adjustments | 46.23M | 14.66M | 25.80M | -9.65M | -22.91M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 895.13M | 957.49M | 971.09M | 694.80M | 311.70M |